Search results
Results from the WOW.Com Content Network
Opioid drugs are known to cause opioid-induced constipation (OIC) by inhibiting gastric emptying and decreasing peristaltic waves leading to delayed absorption of medications and more water absorption from the feces. That can result in hard and dry stool and constipation for some patients. [2]
In older adults, opioid use is associated with increased adverse effects such as "sedation, nausea, vomiting, constipation, urinary retention, and falls". [66] As a result, older adults taking opioids are at greater risk for injury. [67] Opioids do not cause any specific organ toxicity, unlike many other drugs, such as aspirin and
The withdrawal from various opioid medications, including morphine, causes similar effects, most of which is caused by stimulation and over-stimulation of the central nervous system. [ 9 ] [ 7 ] The effects of morphine withdrawal can range from gastrointestinal disturbances to symptoms like tremors (involuntary shaking, most commonly in hands ...
Oxycodone is used for managing moderate to severe acute or chronic pain when other treatments are not sufficient. [15] It may improve quality of life in certain types of pain. [25] Numerous studies have been completed, and the appropriate use of this compound does improve the quality of life of patients with long term chronic pain syndromes ...
Now, as she thinks back on using while she was incarcerated, she recalls, "It was like, okay, you have to scrounge. You have to find it, really kind of get into the groove of who has what in prison."
Laxatives are designed for constipation, not weight loss, and can lead to serious side effects and dangerous complications when used incorrectly. When you lose weight on laxatives, it's from water ...
A 2008 study demonstrated a significant reduction in constipation. [6] Oxycodone/naloxone was released in 2014 in the United States, [5] in 2006 in Germany, and has been available in some other European countries since 2009. In the United Kingdom, the 10 mg oxycodone / 5 mg naloxone and 20 mg / 10 mg strengths were approved in December 2008 ...
A recent abstract presented at the annual meeting of the Radiological Society of North America suggested that levothyroxine use in people with typical hormone ranges could lead to lower bone mass ...